DOI: 10.1055/s-00022861

Aktuelle Kardiologie

LinksSchließen

Referenz

Holmes jr. DR, Cannon LA, Stråhle E et al.
Four-year follow-up of the SYNTAX trial: optimal revascularization strategy in patients with three-vessel disease and/or left main disease.

San Francisco: TCT; 2011

Bibliographische Angaben herunterladen